Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 31

Trial Status

Recruiting3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT06559696Phase 3Recruiting
Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy
Breast Cancer
PrincipalinvestigatorStart date: 2024-07-15
NCT06510660Phase 2Recruiting
Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC
BiomarkersEsophageal Squamous Cell CarcinomaImmunotherapy
PrincipalinvestigatorStart date: 2024-04-11

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Fujian Medical University Union Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jian Liu (jianliu@nankai.edu.cn), PhD

Nankai University

Very Similar
4 trials

Shared therapeutic areas:

Esophageal Squamous Cell CarcinomaAcute Lung InjuryBiomarkers+3 more

Worked with same sponsors:

Beijing Continent Pharmaceutical Co, Ltd.Fujian Medical University Union Hospital+1 more
Collaborated on 3 trials
Similarity Score72%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Breast CancerPrevention

Worked with same sponsors:

Fujian Medical University Union Hospital
Similarity Score10%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Breast CancerEsophageal Squamous Cell Carcinoma
Similarity Score10%

Amir Goren, PhD

Geisinger Clinic

Related
23 trials

Shared therapeutic areas:

Breast CancerPrevention
Similarity Score10%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score5%

Olivier Beauchet, MD

Jewish General Hospital

Related
19 trials

Shared therapeutic areas:

Prevention
Similarity Score5%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score5%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score5%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score5%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Immunotherapy
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06559696Phase 3PrincipalInvestigator

Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy

Breast Cancer
Recruiting
NCT06510660Phase 2PrincipalInvestigator

Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC

BiomarkersEsophageal Squamous Cell CarcinomaImmunotherapy
Recruiting
NCT05704166Phase 2PrincipalInvestigator

PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients

Acute Lung InjuryPrevention
Recruiting

All 3 trials loaded